Pei, male,/kloc-0, born on May 20th, 1962, is the leader and chief scientist of the overall expert group of major special projects of national "863 Program" organization and organ engineering; Director of the Institute of Blood Transfusion Medicine, Academy of Military Medical Sciences; Director of Stem Cell and Regenerative Medicine Research Center, Academy of Military Medical Sciences; Director of China People's Liberation Army Blood Supervision and Appraisal Center. Executive director of China Society of Cell Biology and vice chairman of China Society of Experimental Hematology.
Chinese name: Pei
Nationality: China.
Ethnic group: Han nationality
Date of birth:1May 20, 962
Occupation: Doctor of Medicine
Graduate School: Academy of Military Medical Sciences
Main achievements: "Best Scientific Contribution Award" of Regenerative Medicine Conference.
Representative works: Pei's stem cell technology; Pei's stem cell biology.
Personal realization
He has published more than 0/00 papers/kloc in academic journals at home and abroad such as ExpHematol, LeukRes, CancerJ, StemCells, Chinese Journal of Hematology and acta physiologica sinica. Editor-in-chief and deputy editor-in-chief, participated in the compilation of five monographs. In 2005, he won the only highest honor award of the Second World Congress of Regenerative Medicine-Paul Fraser's "Best Scientific Contribution Award", which is the highest award of China scientists in this field-which indicates that China has occupied an important position in the international field of regenerative medicine.
Representative papers
Pei, et al. (1988) Dynamic observation of CFU-S in unstable and relatively stable culture systems. Acta physiologica sinica, 40(6):569-576.
PeiXT et al. ( 1990)preferentialspressionflowfmolecularweight naturalcolumpressorofhumanfetaliverroriginthegrowthfleukemiccellsinvitor。 ExpHematol， 18(8):927-93 1。
PeiXT et al. (1992) Preliminary application of autologous bone marrow transplantation. CancerJ，5(3): 142- 145。
Pei Xuetao et al. (1995)GM-CSF and IL-3 promote the implantation of CD34+ cells from umbilical cord blood into adult bone marrow matrix. Acta physiologica sinica, 47 (5): 485-490
(1996) Isolation and identification of CD34+hematopoietic progenitor cells and their subsets (CD34+CD38+ and CD34+CD38-). High-tech communication, 6 (1): 42-46
Pei, et al. (1997) Experimental study on expansion of CD34+ cells from umbilical cord blood and improvement of transplantation efficiency. Chinese Journal of Hematology,18 (3):133-136.
Pei, et al. (1999) Experimental study on hematopoietic function reconstruction of SCID mice by expanding hematopoietic cells in vitro. China medical journal, 79 (7): 497-50 1
Pei Xuetao. (1999) who is hematopoietic stem cell: CD34+orCD34_? International Journal of Human Genetics, 70(4):2 13-2 15.
Pei Xue Tao. Research progress of (200 1) stem cells. China Academy of Sciences 200 1 Scientific Development Report, pp70-74, Science Press.
Pei Xue Tao. (2002) Stem cells, human cloning and their ethical issues. China Academy of Sciences' Scientific Development Report in 2002, PP11-116, Science Press.